Dr. O'Brien in a clinic
The MUSC Hematology/Oncology Fellowship Program began in 1986 and currently accepts four trainees into each class of the three-year combined hematology/oncology training program, the only hematology/oncology training program in the state of South Carolina. This program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation. Training in the basic principles and practice of hematology/oncology clinical research is provided to all fellows; additional training in basic and/or clinical research is available. The program also offers an opportunity for select fellows to obtain a Master's Degree in Clinical Research starting in parallel with the final year of fellowship training.
In general, the first two years of training are focused on standard clinical matters leading to completion of all board certification requirements. The rest of the second and all of the third year is flexible, individualized based upon the fellow's interest and as guided by their career pathway. The Scope of Practice includes details about the pathways and the expectations. Fellows also serve as educators for lower-level trainees and participate in institutional quality improvement activities, such as the American Society of Clinical Oncology's Quality Oncology Practice Initiative (QOPI).
The program only accepts July 1 matriculates, and applications for matriculation in a given year are accepted only through the AAMC's ERAS system beginning July 1st, twelve months prior to the intended date of matriculation; the program has participated in the NRMP's "Match" system for assignment of hematology/oncology fellowship positions since 2006 and presently plans to continue its participation. All applications for matriculation July 1, 2013 should be completed no later than August 20, 2012 in order to be considered. Interview dates will be September 7, 21 and October 5, 2012. The program is willing to consider applicants who are not U.S. citizens. Applicants must be considered actively board-certified or board-eligible in internal medicine by the American Board of Internal Medicine or presently be in an internal medicine training program leading to such certification. Candidates who have passed the USMLE Step 3 exam are preferred, as passage of Step 3 is an institutional requirement for fellowship matriculation.
The members of the Hematology/Oncology Faculty are active participants in the Hollings Cancer Center. The Hollings Cancer Center has attained National Cancer Institute (NCI) designation, a distinction held by only 65 other cancer centers in the United States, and the only such institution in the state.
The Hematology/Oncology Fellowship is fully integrated with the basic and clinical research programs at the Hollings Cancer Center. Fellows are expected to take advantage of the clinical and laboratory research activities and opportunities of the Cancer Center, including the grant mechanisms.
The Division takes pride in our ability to collaborate and form teams of investigators nationally and internationally to advance research in hematology and oncology.
It is our commitment to basic and clinical research, which allows us to improve the preventive, diagnostic and therapeutic services to our patients.
This section provides details on our ongoing research and investigational capabilities available in our Division.
Read the program's full Educational Program Description document
Read the Scope of Practice document